Sign In

Dan Cowell

COO at Momentous Therapeutics

Dan Cowell is an experienced biotech executive currently serving as the Chief Operating Officer at Momentous Therapeutics Ltd.12 Here are some key details about his background and career:

Professional Experience

Dan Cowell has over 25 years of experience in the biotech industry, with a proven track record of managing and co-founding innovative companies.2 His career highlights include:

  • Chief Operating Officer at Momentous Therapeutics Ltd (2022-present)13
  • CEO of Psyomics Ltd (2015-2020)1
  • Chief Operating Officer at Horizon Discovery (2010-2014)1
  • Co-founder and CEO of Hypoxium (2008-2010)1
  • Co-founder and Director of Pharmorphix (2003-2007)1

Education and Expertise

Dan Cowell holds a Bachelor of Science degree in Chemistry from the University of Kent.1 His areas of expertise include:

  • Drug discovery and development
  • Biotechnology
  • Cell biology
  • Oncology
  • Genomics
  • Research and development

Board Positions

In addition to his executive roles, Dan has served on several boards:

  • Non-Executive Director at Sentinel Oncology since 20112
  • Non-Executive Director at Techspert.io (2016-2020)1
  • Non-Executive Director at Euprotec Ltd (2010-2014)1

Entrepreneurial Background

Dan Cowell has a strong entrepreneurial background, having:

  • Co-founded and managed multiple biotech companies
  • Taken three research services companies from foundation to exit
  • Led a gene editing company from start-up to IPO as COO
  • Co-founded and managed a digital mental health diagnostics platform2

Current Role at Momentous Therapeutics

As the Chief Operating Officer at Momentous Therapeutics Ltd, Dan Cowell is part of the leadership team driving the company's mission in biotechnology research and development.34 His extensive experience in drug discovery and company management makes him well-suited for this role in an innovative therapeutics company.

Highlights

Jul 22 · linkedin

Can anyone in my network recommend someone for a part-time/ consulting CFO role? I'm working with two companies with a need in this area. One at pre-seed stage in drug discovery and one in drug discovery heading towards Phase I. Both exciting companies!

Oct 6 · linkedin

Congratulations to Graham Mills, PhD, Dave Holden-White and the team at techspert.io on their raise of $12m led by BGF and Nauta Capital Since experiencing the pain points and inefficiencies first hand while trying connect to experts in the healthcare sector - they have gone on to create a platform that goes way beyond their initial challenge. By applying AI and machine learning they have redefined how we can index and access over 200 million experts worldwide, covering millions of expertise areas. This round is another great milestone, validating their technical, commercial and real world use of AI/ machine learning to address the problem of the intensive human capital that is required in the traditional search process.

Related Questions

What are Dan Cowell's key achievements at Momentous Therapeutics?
How did Dan Cowell transition from drug discovery to digital mental health diagnostics?
What companies has Dan Cowell co-founded and what were their outcomes?
What is Dan Cowell's educational background and how has it influenced his career?
How has Dan Cowell's role evolved at Momentous Therapeutics since joining in 2022?
Dan Cowell
Dan Cowell, photo 1
Dan Cowell, photo 2
Add to my network

Location

Greater Cambridge Area